© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Experts review the challenges of managing OFF episodes in Parkinson disease and the current treatment options to optimize therapy.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Indu Subramanian, MD.
January 22, 2021
This fourth-generation system since 2012 is indicated as adjunctive therapy for stimulation of the subthalamic nucleus and internal globus pallidus to treat Parkinson symptoms.
January 21, 2021
The harmful association seen with antidepressants is complicated by their need in patients with HD and mood disturbance. There were also associations identified with alcohol and substance use.
The associate professor at Hokkaido University and investigator of STEMTRA also discussed other efforts in stroke, Alzheimer disease, and Parkinson disease.
January 18, 2021
Further associations with lowered risk of Parkinson were observed with BMI and coffee intake.
Here's what is coming soon to NeurologyLive.
January 16, 2021
The chief medical officer of Cerevel Therapeutics detailed phase 2 data of its investigational agent tavapadon, which has been studied in patients with Parkinson disease.
January 15, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 15, 2021.
January 13, 2021
Men were observed to derive benefit from a Greek Mediterranean diet and women were found to generally adhere more closely to diet interventions than men.
The clinical fellow at Massachusetts General Hospital detailed his research on neurology resident EEG education, and the increased need for more consistency throughout programs.
January 12, 2021
The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.